LOW FLAT RATE AUST-WIDE $9.90 DELIVERY INFO

Close Notification

Your cart does not contain any items

$74.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Oxford University Press
27 September 2011
In the last decade, advances in the understanding of lipoprotein and lipid metabolism have developed enormously. This has resulted in a detailed knowledge of the mechanisms underlying the primary and secondary dyslipidaemias. Furthermore, the role of lipoproteins in atherogenesis is increasingly understood at the cellular and molecular level. In this book, the scale of the problem of cardiovascular disease (CVD) is described together with the possibilities for prevention. The pathophysiology of lipid and lipoproteins provide a background to the understanding of the primary and secondary dyslipidaemias and the mechanism of action of the different drug classes.

A practical approach to therapy is provided including diet, lifestyle, and therapeutic approaches. Common clinical problems are addressed and the book looks to the future, principally in relation to new therapeutic targets. This book provides the basis for the translation of clinical trial science into everyday clinical practice for the benefit of the individual patient.
Edited by:  
Imprint:   Oxford University Press
Country of Publication:   United Kingdom
Dimensions:   Height: 180mm,  Width: 101mm,  Spine: 8mm
Weight:   146g
ISBN:   9780199543502
ISBN 10:   019954350X
Series:   Oxford Cardiology Library
Pages:   168
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
1: Professor Guy De Backer: Epidemiology of cardiovascular disease: the scale of the problem 2: Joanna Gouni-Berthold and Wilhelm Krone: Lipids, lipoproteins and atherogenesis 3: Catherine McGorrian, Tora Leong, Ralph D'Agostino, Marie-Therese Coney and Ian M. Graham: Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN and QRISK 4: Anton F. H. Stalenhoef: Primary dyslipidaemias 5: Rafael Carmena and José T Real: Secondary dyslipidemias 6: Jonathan Morrell and Jacqueline Morrell: Diet and lifestyle 7: D. John Betteridge: Pharmacological therapy: Statins 8: D. John Betteridge: Pharmacological therapy: Non-Statin Drugs 9: Anthony S. Wierzbicki: Combination therapy for the management of hyperlipidaemia 10: D. John Betteridge: Recent lipid-lowering trials in perspective: Implications for therapy 11: Manish Kalla and Julian Halcox: Vascular imaging 12: John Reckless: Common problems in lipid management

John Betteridge is Professor of of Endrocrinology and Metabolism at University College, London UK.

See Also